Abstract
MO58-2 Differences in treatment response to CDK4/6 inhibitors and endocrine therapy between HER2-negative and HER2-low expression groups
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
